Gastroenterology and Hepatology

Track2:Microbiome and Gut Health

The human microbiome, composed of trillions of bacteria, fungi, viruses, and other microorganisms, plays a crucial role in maintaining overall health, including liver function. The gut-liver axis refers to the bidirectional communication between the gastrointestinal (GI) tract and the liver. The microbiome influences liver health through various mechanisms, including immune modulation, metabolism, and the detoxification process.

• Gut Microbiome and Liver Disease: An imbalance in the gut microbiome, known as dysbiosis, has been linked to several liver diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), cirrhosis, and liver cancer (HCC). Dysbiosis can lead to increased intestinal permeability ("leaky gut"), allowing harmful substances, such as endotoxins, to enter the bloodstream.
   
• Microbiome in NAFLD and NASH: In the context of NAFLD and NASH, gut microbiota imbalances contribute to the accumulation of fat in the liver, insulin resistance, and inflammatory responses that aggravate liver injury. Studies suggest that microbiome therapies, such as probiotics, prebiotics, and dietary interventions, may improve liver function by restoring microbial balance and reducing inflammation.
   
• Liver Detoxification and Metabolism: The gut microbiome also affects the liver's role in detoxifying harmful substances. Certain gut bacteria produce short-chain fatty acids (SCFAs) like butyrate, which help maintain gut barrier function and regulate the liver's metabolic processes. The gut microbiota also influences the liver’s ability to metabolize drugs, alcohol, and other toxic substances, making it a key player in detoxification.